Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ) SHZ

11.71

-0.19(-1.60%)

Updated at December 05 03:04PM

Currency In CNY

Valuation

Market Cap3.29B
Enterprise Value2.95B
P/E Ratio36.08
PEG Ratio3.61
Price/Sales Ratio4.48
Price/Book Ratio1.87
Enterprise/Revenue4.31
Enterprise/EBITDA29.5

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.12
Operating Margin0.14

Management Effectiveness

Return On Assets0.04
Return On Equity0.05

Income Statement

Revenue1.1B
Revenue/Share2.61
Gross Profit633.14M
EBITDA228.51M
Net Income91.76M
Diluted EPS0.23

Balance Sheet

Total Cash452.97M
Total Cash/Share1.13
Total Debt126.83M
Total Debt/Equity0.05
Current Ratio2.3
Book Value Per Share6.32

Price History

52-Week Change24.31
52-Week High13.56
52-Week Low6.71
Moving Average 50 Days11
Moving Average 200 Days9.78

Statistics

Average Volume24.05M
Shares Outstanding401.74M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.07
Trailing Annual Dividend Yield0.59
Payout Ratio0.22
Last Split Factor9:5
Last Split DateOctober 12, 2018